BE642575A - - Google Patents

Info

Publication number
BE642575A
BE642575A BE642575DA BE642575A BE 642575 A BE642575 A BE 642575A BE 642575D A BE642575D A BE 642575DA BE 642575 A BE642575 A BE 642575A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Publication of BE642575A publication Critical patent/BE642575A/xx
Priority claimed from US251747A external-priority patent/US3127430A/en
Priority claimed from US251744A external-priority patent/US3127428A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • AHUMAN NECESSITIES
    • A63SPORTS; GAMES; AMUSEMENTS
    • A63FCARD, BOARD, OR ROULETTE GAMES; INDOOR GAMES USING SMALL MOVING PLAYING BODIES; VIDEO GAMES; GAMES NOT OTHERWISE PROVIDED FOR
    • A63F1/00Card games
    • A63F1/06Card games appurtenances
    • A63F1/18Score computers; Miscellaneous indicators
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Multimedia (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE642575D 1963-01-16 BE642575A (US07534539-20090519-C00280.png)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US251747A US3127430A (en) 1963-01-16 1963-01-16 17alpha-methyl-1, 5-androstadienes-17beta-ol-3-one and derivatives thereof
US251744A US3127428A (en) 1963-01-16 1963-01-16 Process for converting a 3-keto-delta-steroid to the corresponding 3-keto delta-compound
US263441A US3332967A (en) 1963-01-16 1963-03-07 3-hydroxy-1, 5-bis-dehydro steroids and methods for their manufacture

Publications (1)

Publication Number Publication Date
BE642575A true BE642575A (US07534539-20090519-C00280.png)

Family

ID=27400477

Family Applications (1)

Application Number Title Priority Date Filing Date
BE642575D BE642575A (US07534539-20090519-C00280.png) 1963-01-16

Country Status (9)

Country Link
US (1) US3332967A (US07534539-20090519-C00280.png)
BE (1) BE642575A (US07534539-20090519-C00280.png)
BR (1) BR6456127D0 (US07534539-20090519-C00280.png)
CH (1) CH471829A (US07534539-20090519-C00280.png)
DE (2) DE1493145B1 (US07534539-20090519-C00280.png)
DK (1) DK121120B (US07534539-20090519-C00280.png)
ES (1) ES295331A1 (US07534539-20090519-C00280.png)
FR (2) FR1602256A (US07534539-20090519-C00280.png)
SE (1) SE321468B (US07534539-20090519-C00280.png)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3928398A (en) * 1973-11-01 1975-12-23 Richardson Merrell Inc Derivatives of 7{60 -methylestr-4-en-3{60 ,17{62 -diol
US4340538A (en) * 1980-07-21 1982-07-20 The Upjohn Company Process for producing 6α-fluoro-Δ1,4 -3-keto steroids
US4383947A (en) * 1981-07-24 1983-05-17 The Upjohn Company Introduction of a fluorine atom
US5879711A (en) * 1997-11-07 1999-03-09 Sequeira; Joel A. Stable antiandrogenic gel composition
WO2004089304A2 (en) * 2003-04-01 2004-10-21 Hollis-Eden Pharmaceuticals, Inc. Antiandrogens with marginal agonist activity and methods of use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3127430A (en) * 1963-01-16 1964-03-31 Schering Corp 17alpha-methyl-1, 5-androstadienes-17beta-ol-3-one and derivatives thereof
US3127428A (en) * 1963-01-16 1964-03-31 Schering Corp Process for converting a 3-keto-delta-steroid to the corresponding 3-keto delta-compound

Also Published As

Publication number Publication date
BR6456127D0 (pt) 1973-07-17
DK121120B (da) 1971-09-13
DE1793618C3 (de) 1975-10-23
SE321468B (US07534539-20090519-C00280.png) 1970-03-09
DE1793618B2 (US07534539-20090519-C00280.png) 1975-03-06
DE1493145B1 (de) 1971-11-25
DE1793618A1 (de) 1972-02-03
FR1602256A (en) 1970-11-02
CH471829A (de) 1969-04-30
FR4300M (US07534539-20090519-C00280.png) 1966-07-25
ES295331A1 (es) 1964-06-01
US3332967A (en) 1967-07-25

Similar Documents

Publication Publication Date Title
AR142945A1 (US07534539-20090519-C00280.png)
FR4300M (US07534539-20090519-C00280.png)
AT260747B (US07534539-20090519-C00280.png)
BE627012A (US07534539-20090519-C00280.png)
BE623117A (US07534539-20090519-C00280.png)
BE31062A (US07534539-20090519-C00280.png)
BE627172A (US07534539-20090519-C00280.png)
BE627151A (US07534539-20090519-C00280.png)
BE627145A (US07534539-20090519-C00280.png)
BE462764A (US07534539-20090519-C00280.png)
BE627141A (US07534539-20090519-C00280.png)
BE627083A (US07534539-20090519-C00280.png)
BE627025A (US07534539-20090519-C00280.png)
BE627023A (US07534539-20090519-C00280.png)
BE626986A (US07534539-20090519-C00280.png)
BE626938A (US07534539-20090519-C00280.png)
BE626915A (US07534539-20090519-C00280.png)
BE465565A (US07534539-20090519-C00280.png)
BE626867A (US07534539-20090519-C00280.png)
BE626826A (US07534539-20090519-C00280.png)
BE626803A (US07534539-20090519-C00280.png)
BE626590A (US07534539-20090519-C00280.png)
BE626358A (US07534539-20090519-C00280.png)
BE612803A (US07534539-20090519-C00280.png)
BE625828A (US07534539-20090519-C00280.png)